IGF axis gene expression patterns are prognostic of survival in epithelial ovarian cancer
Open Access
- 1 September 2007
- journal article
- Published by Bioscientifica in Endocrine-Related Cancer
- Vol. 14 (3) , 781-790
Abstract
The IGF axis has documented growth-promoting effects in various malignancies, but its role in epithelial ovarian cancer (EOC) has not been adequately examined. We studied the expression of the IGF axis genes in relation to outcome in EOC. Microarray expression profiles from 64 patients with advanced-stage EOC were used. Two multi-gene subsets were chosen, one upstream of the IGF receptor (‘IGF family’) and the other downstream of the IGF receptor (‘IGF signaling pathway’), and analyzed in relation to survival. In addition, expression patterns of the two gene subsets were analyzed in relation to favorable and unfavorable prognosis categories identified in a previous study by whole-genome expression profiling. In a gene-by-gene analysis, IGF binding protein 4 and IGF-II receptor gene expression was inversely associated with survival. Using hierarchical clustering, the two multi-gene subsets separated the patient cohort into two groups with different median survival (IGF family: 33 vs 63 months, P=0.02 and IGF signaling pathway: 41 vs 63 months, P=0.05). Furthermore, the two multi-gene subsets were differentially expressed between the previously defined favorable and unfavorable prognosis tumors (Kolmogorov–Smirnov permutation: P=0.0005 and 0.003 for the IGF family and signaling pathway respectively), and individual genes (including IGF-I, IGF-I receptor, and several genes downstream of the receptor) were overexpressed in unfavorable prognosis tumors (permutation P<0.05). The expression patterns of several genes in the IGF axis are associated with survival in EOC, and expression changes of these genes may be underlying previously proposed microarray-derived clinical prognostic models. Future studies are needed to more precisely determine the diagnostic and potential therapeutic significance of these findings.Keywords
This publication has 38 references indexed in Scilit:
- Insulin-like growth factor receptor I targeting in epithelial ovarian cancerGynecologic Oncology, 2006
- High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancerGynecologic Oncology, 2005
- Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumorsCancer Cell, 2004
- Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancerUrologic Oncology: Seminars and Original Investigations, 2004
- A Mechanism of Cyclin D1 Action Encoded in the Patterns of Gene Expression in Human CancerCell, 2003
- The insulin-like growth factor system and cancerCancer Letters, 2003
- Circulating levels of insulin‐like growth factor‐I and risk of ovarian cancerInternational Journal of Cancer, 2002
- Insulin-like growth factor I (IGF-I), IGF-binding protein-3 and prostate cancer risk: epidemiological studiesGrowth Hormone & IGF Research, 2000
- Differential IGF-independent effects of insulin-like growth factor binding proteins (1-6) on apoptosis of breast epithelial cellsJournal of Cellular Biochemistry, 1999
- Biological Characterization of Human Epithelial Ovarian Carcinoma Cells in Primary Culture: The Insulin-like Growth Factor SystemExperimental Cell Research, 1998